Zeo ScientifiX (ZEOX) Depreciation & Amortization (CF) (2016 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Depreciation & Amortization (CF) of $19000.0 for Q2 2026, up 18.75% year-over-year from $16000.0 in Q2 2025, and little changed quarter-over-quarter from $19000.0 in Q1 2026.
Zeo ScientifiX (ZEOX) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends
Zeo ScientifiX's Depreciation & Amortization (CF) history runs 11 years deep, the most recent figure standing at $19000.0 for Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) rose 18.75% year-over-year to $19000.0; the TTM figure through Apr 2026 stood at $77000.0 (up 10.0% YoY), while the FY2025 annual figure was $73000.0, down 1.35% from the prior year.
- Depreciation & Amortization (CF) for Q2 2026 stood at $19000.0, roughly flat from $19000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $262797.0 in Q4 2022, with the low at $14170.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $19000.0 (2024), against an average of $55750.4.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) jumped 1685.18% in 2022, then sank 93.91% in 2023.
- Zeo ScientifiX's Depreciation & Amortization (CF) stood at $262797.0 in 2022, then tumbled by 93.91% to $16000.0 in 2023, then increased by 12.5% to $18000.0 in 2024, then rose by 11.11% to $20000.0 in 2025, then fell by 5.0% to $19000.0 in 2026.
- Business Quant data shows ZEOX's Depreciation & Amortization (CF) at $19000.0 in Q2 2026, $19000.0 in Q1 2026, and $20000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 19,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 19,000.00 |
| Apr 30, 2026 | 19,000.00 |
| Jan 31, 2026 | 19,000.00 |
| Jan 31, 2026 | 19,000.00 |
| Oct 31, 2025 | 20,000.00 |
| Oct 31, 2025 | 20,000.00 |
| Jul 31, 2025 | 19,000.00 |
| Jul 31, 2025 | 19,000.00 |
| Apr 30, 2025 | 16,000.00 |
| Apr 30, 2025 | 16,000.00 |
| Jan 31, 2025 | 18,000.00 |
| Jan 31, 2025 | 18,000.00 |
| Oct 31, 2024 | 18,000.00 |
| Oct 31, 2024 | 18,000.00 |
| Jul 31, 2024 | 18,000.00 |
| Jul 31, 2024 | 18,000.00 |
| Apr 30, 2024 | 19,000.00 |
| Apr 30, 2024 | 19,000.00 |
| Jan 31, 2024 | 19,000.00 |
| Jan 31, 2024 | 19,000.00 |